Treatment of polycystic ovary patients undergoing IVF
- PMID: 9013302
- PMCID: PMC3454708
- DOI: 10.1007/BF02765743
Treatment of polycystic ovary patients undergoing IVF
Abstract
We believe that PCO patients can achieve good results in IVF cycles, provided that stimulation protocols appropriate to their hormonal profiles are used.
The dose of gonadotropin used seems to be more important than the type of gonadotropin. If there is a risk of ovarian hyperstimulation, it is useful to employ one of the strategies recommended to prevent development of genuine OHS, which may endanger the patient’s health.
References
-
- Asch RH, Ivery G, Goldsman M, Frederick JL, Stone SC, Balmaceda JP. The use of intravenous albumin in patients at high risk for severe OHSS. Hum Reprod. 1993;8:1015–1020. - PubMed
-
- Barri PN: Respuesta Anomala a la Estimulacion de la Maduracion Folicular en FIV. Doctoral thesis, Universidad de Barcelona, Barcelona
-
- Balasch J, Jove Y, Moreno V, Civico S, Puerto B, Vanrell JA. The comparison of two GnRHa in an IVF program. Fertil Steril. 1992;58(5):991–994. - PubMed
-
- Balen AH, Tan SL, Jacobs HS. Hypersecretion of luteinizing hormone: A significant cause of infertility and miscarriage. Br J Obstet Gynaecol. 1993;100:1082–1089. - PubMed
-
- Berg C, Hamberger L. Cumulative birth rates by IVF including cryopreservation of all embryos. Assist Reprod Rev. 1995;5:195–200. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical